PlainPill

Hydroxocobalamin

People mainly take Hydroxocobalamin for energy. Based on 6 first-hand reports and 12 meta-analyses & systematic reviews in the medical literature. Ranked #546 of 1,974 overall.

25
User score
Mostly positive
50% positive0% mixed0% negative50% unclear

Of reports that state an outcome, 100% are positive.

Clinical research
AStrong research base
12
meta-analyses
15
RCTs
1,105
papers

What Hydroxocobalamin does, according to users

Of the people who reported each effect, the share who said it got better.

betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

Shock · 2025 · Meta-analysis / systematic review
ADJUNCTIVE VASOPRESSORS AND SHORT-TERM MORTALITY IN ADULTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS

Conclusion: Conclusions: In adults with septic shock, adjunctive vasopressors may lower short-term death risk and likely lower kidney replacement therapy risk, but may increase risk of adverse effects. In the United States, adjunctive vasopressor use prevalence in septic shock is disconnected from the low evidence certainty for a favorable mortality-to-risk profile.

PubMed 39965613 ↗
Clin Toxicol (Phila) · 2021 · Meta-analysis / systematic review
Sodium azide poisoning: a narrative review

Conclusion: Recent increases in azide poisoning reports may stem from greater commercial use and availability. Treatment of systemic poisoning may require aggressive hemodynamic support due to profound hypotension. Based on mechanistic considerations, hydroxocobalamin is a rational choice for treating azide poisoning.

PubMed 34128439 ↗
Crit Care · 2024 · Meta-analysis / systematic review
Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials

Conclusion: Administration of non-adrenergic vasopressors was significantly associated with reduced mortality in patients with septic shock. However, no single agent achieved statistical significance in separate analyses. Although the pooled effects of non-adrenergic vasopressors on survival did not reach statistical significance in patients undergoing cardiac or non-cardiac surgery, the confidence intervals included the possibility of both no effect and a clinically important benefit from non-adrenergic agents. These findings justify the conduct of further RCTs comparing non-adrenergic vasopressors to us

PubMed 39736782 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

occasionallyas reported

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“Hydroxo seems clean but I occasionally use Cyano as it's cheap”
Source discussion ↗
“occasionally hydroxocobalamin ... when I want some extra energy”
Source discussion ↗
“Started taking Folinic Acid and Hydroxocobalamin, noticed difference like night and day.”
Source discussion ↗
“Hydroxocobalamin is tolerated by under and overmethylators”
Source discussion ↗
“Hydroxocobalamin raised a lot (to 700) but i didnt felt any improvement except the day I took injection I felt tiny bit more alive”
Source discussion ↗
Top discussions (5)

Other options for energy

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate